Talquetamab
Janssen
['mmsm']
the talquatemab data looks pretty spectacular. the impact of dose and schedule on the skin/nail/dysguesia stuff needs to be examined closely. #ash22 #mmsm 
Hematologist fighting #myeloma & #amyloidosis @ Karmanos Cancer Institute in Detroit, MI #mmsm disclosures/COI @ https://t.co/mu65ySxdz8